P
Parveen
About Parveen
Data last updated:
Parveen is a Director at Rx Plus Pharmaceuticals Private Limited (since 2023) and Designated Partner at Stelfliers Global Llp (since 2025). The companies operate in Home Appliances, Construction and Business Services. The largest current company by reported revenue is Rx Plus Pharmaceuticals Private Limited at ₹30.6 Lakh (FY 2025). Earlier, Parveen was a Director at Inixy India Private Limited (2019–2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 Jan 2023 | 2023 | ₹30.6 Lakh (FY 2025) | Active | |
| Designated Partner | 22 Jan 2025 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 21 Nov 2019 | 2019 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Parveen
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abhinav Jain | 09479829 | Rx Plus Pharmaceuticals Private Limited , Stelfliers Global Llp | Director |
| Sudha Jain | 09479830 | Rx Plus Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Parveen
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Parveen
Parveen currently holds 2 directorships: Rx Plus Pharmaceuticals Private Limited (Director, since 10 Jan 2023, revenue βΉ30.6 Lakh (FY 2025)); Stelfliers Global Llp (Designated Partner, since 22 Jan 2025).
Parveen was first appointed on 21 Nov 2019 as Director at Inixy India Private Limited. The most recent appointment on record is 22 Jan 2025 at Stelfliers Global Llp.
Parveen held 1 earlier board appointment: Inixy India Private Limited (Director, 21 Nov 2019 to 31 May 2022).
The current boards of Parveen's companies include Abhinav Jain (Rx Plus Pharmaceuticals Private Limited), Sudha Jain (Rx Plus Pharmaceuticals Private Limited).